Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
VACCINE PROFILES
Read series
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
23 May 2016
World Humanitarian Summit - Gavi's Fragility and Immunisation Policy
22 April 2016
Gavi tackling environmental challenges head on
17 March 2016
Gavi welcomes new record low price for pneumococcal vaccine
11 February 2016
Japan commits US$ 18.5 million to support immunisation in Ebola-affected region
5 February 2016
Study shows near elimination of Hib disease in Kilifi region of Kenya after introduction of vaccine
3 December 2015
Gavi Board thanks Dagfinn Høybråten for inspirational leadership
26 November 2015
Organisation of Islamic Cooperation approves Gavi membership to key health committee
12 November 2015
Unprecedented number of children protected against pneumonia with Gavi support
23 October 2015
Gavi and Global Fund statement on malaria vaccine recommendations
6 October 2015
New commitment from the Republic of Korea to Gavi will support childhood immunisation in the world's poorest countries
28 September 2015
Gavi welcomes global goals and renews call for immunisation indicator
9 September 2015
China seals commitment to support immunisation in developing countries